Filing Details

Accession Number:
0001437749-19-005236
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-19 09:59:03
Reporting Period:
2019-03-18
Accepted Time:
2019-03-19 09:59:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337013 Infusystem Holdings Inc INFU Surgical & Medical Instruments & Apparatus (3841) 203341405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1519525 R. Christopher Sansone C/O Infusystem Holdings, Inc.
31700 Research Park Drive
Madison Heights MI 48071
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-18 20,000 $4.36 1,416,264 No 4 P Indirect See
Common Stock Acquisiton 2019-03-18 5,000 $4.36 298,388 No 4 P Indirect See
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See
No 4 P Indirect See
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 0 Direct
Footnotes
  1. The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  2. The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.